title: In vivo monitoring of natural killer cell trafficking during tumor immunotherapy.
abstract: Natural killer (NK) cells are a crucial part of the innate immune system and play critical roles in host anti-viral, anti-microbial, and antitumor responses. The elucidation of NK cell biology and their therapeutic use are actively being pursued with 200 clinical trials currently underway. In this review, we outline the role of NK cells in cancer immunotherapies and summarize current noninvasive imaging technologies used to track NK cells in vivo to investigate mechanisms of action, develop new therapies, and evaluate efficacy of adoptive transfer.
authors.affiliation: Biology and Biological Engineering, Beckman Institute, California Institute of Technology, Pasadena, CA, USA.
authors.forename: Naomi S
authors.initials: NS
authors.lastname: Sta Maria
authors.affiliation: Biology and Biological Engineering, Beckman Institute, California Institute of Technology, Pasadena, CA, USA.
authors.forename: Samuel R
authors.initials: SR
authors.lastname: Barnes
authors.affiliation: Biology and Biological Engineering, Beckman Institute, California Institute of Technology, Pasadena, CA, USA.
authors.forename: Russell E
authors.initials: RE
authors.lastname: Jacobs
keywords: MRI; PET imaging; cell tracking; immunotherapy; natural killer cells; optical imaging
references.citation: Cancer Res. 2005 Dec 1;65(23):11136-45
references.pmid: 16322264
references.citation: Cancer Immunol Immunother. 2000 Mar;48(12):703-13
references.pmid: 10752478
references.citation: Stem Cells Dev. 2004 Jun;13(3):307-14
references.pmid: 15186726
references.citation: Cancer Res. 2013 Mar 15;73(6):1892-9
references.pmid: 23302230
references.citation: Immunol Cell Biol. 1999 Dec;77(6):499-508
references.pmid: 10571670
references.citation: Nature. 2001 Feb 22;409(6823):1055-60
references.pmid: 11234016
references.citation: J Immunol Methods. 1994 Sep 30;175(1):79-87
references.pmid: 7930641
references.citation: Nucl Med Biol. 2008 Jul;35(5):579-88
references.pmid: 18589302
references.citation: Clin Exp Immunol. 2009 Mar;155(3):504-13
references.pmid: 19220837
references.citation: J Biomed Biotechnol. 2011;2011:379123
references.pmid: 21660134
references.citation: Cancer Immunol Immunother. 2008 Mar;57(3):411-23
references.pmid: 17717662
references.citation: Cytotherapy. 2013 Dec;15(12):1563-70
references.pmid: 24094496
references.citation: J Mol Med (Berl). 2009 Feb;87(2):199-210
references.pmid: 19002424
references.citation: Science. 2011 Jan 7;331(6013):44-9
references.pmid: 21212348
references.citation: J Immunol. 2002 Nov 15;169(10):5754-60
references.pmid: 12421955
references.citation: Cytotherapy. 2008;10(6):625-32
references.pmid: 18836917
references.citation: Eur J Nucl Med Mol Imaging. 2011 May;38(5):949-68
references.pmid: 21170525
references.citation: Cancer Immunol Immunother. 2003 May;52(5):297-308
references.pmid: 12700945
references.citation: Science. 2001 May 4;292(5518):934-7
references.pmid: 11340207
references.citation: Cancer Res. 2010 Aug 1;70(15):6109-13
references.pmid: 20631071
references.citation: Nature. 1992 Jul 2;358(6381):66-70
references.pmid: 1614533
references.citation: J Hematother Stem Cell Res. 2001 Aug;10(4):535-44
references.pmid: 11522236
references.citation: Surgery. 2009 Mar;145(3):286-93
references.pmid: 19231581
references.citation: Cytokine Growth Factor Rev. 2002 Apr;13(2):169-83
references.pmid: 11900992
references.citation: Science. 1995 Apr 21;268(5209):405-8
references.pmid: 7716543
references.citation: Cancer Immunol Immunother. 2013 Aug;62(8):1359-68
references.pmid: 23689729
references.citation: Magn Reson Med. 2011 Mar;65(3):756-63
references.pmid: 20928869
references.citation: Cancer Res. 2004 Jul 1;64(13):4664-9
references.pmid: 15231679
references.citation: Transfusion. 2014 Jun;54(6):1515-21
references.pmid: 24446786
references.citation: Cancer Res. 1993 Dec 15;53(24):5867-71
references.pmid: 8261395
references.citation: Curr Opin Immunol. 2005 Apr;17(2):211-7
references.pmid: 15766683
references.citation: Nat Rev Immunol. 2007 May;7(5):329-39
references.pmid: 17438573
references.citation: J Immunol. 2008 May 1;180(9):6392-401
references.pmid: 18424763
references.citation: J Vis Exp. 2011 Feb 02;(48):
references.pmid: 21339714
references.citation: Blood. 2003 Apr 15;101(8):3052-7
references.pmid: 12480696
references.citation: Nature. 2005 Aug 25;436(7054):1186-90
references.pmid: 15995699
references.citation: Trends Immunol. 2001 Nov;22(11):633-40
references.pmid: 11698225
references.citation: Cancer Lett. 2008 Dec 8;272(1):110-21
references.pmid: 18718708
references.citation: Eur Radiol. 2005 Jan;15(1):4-13
references.pmid: 15616814
references.citation: Nanotechnology. 2009 Nov 25;20(47):475102
references.pmid: 19875875
references.citation: Nat Rev Cancer. 2002 Nov;2(11):850-61
references.pmid: 12415255
references.citation: Anticancer Res. 2005 Nov-Dec;25(6A):3725-32
references.pmid: 16302732
references.citation: Invest Radiol. 2013 Jun;48(6):492-9
references.pmid: 23249649
references.citation: Leuk Res. 2005 Mar;29(3):301-6
references.pmid: 15661266
references.citation: J Comput Assist Tomogr. 2003 Nov-Dec;27(6):825-46
references.pmid: 14600447
references.citation: Mol Imaging. 2009 Jan-Feb;8(1):15-26
references.pmid: 19344572
references.citation: Cytotherapy. 2012 Jul;14(6):743-51
references.pmid: 22443465
references.citation: Nucl Med Commun. 2008 Mar;29(3):193-207
references.pmid: 18349789
references.citation: Blood. 2002 Aug 15;100(4):1265-73
references.pmid: 12149207
references.citation: Front Immunol. 2012 Nov 29;3:347
references.pmid: 23230434
references.citation: Blood. 2005 May 15;105(10):3972-8
references.pmid: 15692062
references.citation: Blood. 2005 Apr 15;105(8):3051-7
references.pmid: 15632206
references.citation: Science. 2002 May 17;296(5571):1323-6
references.pmid: 11950999
references.citation: Blood. 1998 Mar 1;91(5):1706-15
references.pmid: 9473237
references.citation: Cell Mol Immunol. 2013 May;10(3):230-52
references.pmid: 23604045
references.citation: Cancer Immunol Immunother. 2014 Jan;63(1):21-8
references.pmid: 23989217
references.citation: J Transl Med. 2006 Nov 14;4:49
references.pmid: 17105663
references.citation: Biomaterials. 2012 Aug;33(22):5584-92
references.pmid: 22575830
references.citation: Eur J Immunol. 1975 Feb;5(2):112-7
references.pmid: 1234049
references.citation: Front Med. 2012 Mar;6(1):56-66
references.pmid: 22460449